MESO – mesoblast limited - american depositary shares (US:NASDAQ)

News

Ryoncil® Net Revenues Increase for the Quarter to US$30M [Yahoo! Finance]
Ryoncil® Net Revenues Increase for the Quarter to US$30M
Real-World Commercial Experience with Ryoncil® Shows 84% Survival of Children with SR-aGvHD After Completing 28-Days of Treatment
FDA Acknowledges Effects on Pain Intensity Favor Rexlemestrocel-L, Confirms 12-Month Reduction in Back Pain Supports Product Efficacy
Ryoncil® Sales Increase 60% in December Quarter to US$35.1M [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com